United States · FDA National Drug Code directory
Levocarnitine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-762_ad6d92d4-71c1-481a-a7cf-b2d551c5daad
- Product NDC
- 16571-762
- Form
- TABLET
- Composition / generic term
- Levocarnitine
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201201
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCARNITINE — 330 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 BLISTER PACK in 1 CARTON (16571-762-09) / 10 TABLET in 1 BLISTER PACK · 16571-762-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →